Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The New Drug Development for Ischemic Stroke in China

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-061-Tuesday
  • By: WANG, Xiaoliang (Institute of Materia Medica, CAMS, Pharmacology, Beijing, China)
  • Co-author(s): Xiaoliang Wang: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
    Ling wang: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China;Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
    Shaofeng Xu: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
    Nan Feng: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
  • Abstract:

    Backgrounds

    Ischemic stroke is the most fatal reason for permanent disability all over the world. There are about 8 million ischemic stroke patients and more than 1.5 million incidences each year in China. It is a worldwide challenge to develop a new drug for treatment of ischemic stroke.

    Aims

    Several therapeutic agents were developed in last two

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses